Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumothorax | 2 | 2019 | 83 | 0.680 |
Why?
|
| Electric Impedance | 2 | 2019 | 72 | 0.600 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 3 | 2019 | 41 | 0.330 |
Why?
|
| Pleura | 2 | 2019 | 28 | 0.300 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2019 | 86 | 0.290 |
Why?
|
| Abortion, Induced | 1 | 2024 | 82 | 0.200 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2022 | 83 | 0.180 |
Why?
|
| Benzamides | 2 | 2019 | 124 | 0.180 |
Why?
|
| Obstetrics | 1 | 2024 | 245 | 0.170 |
Why?
|
| Hysterectomy | 1 | 2022 | 200 | 0.170 |
Why?
|
| Pyridines | 2 | 2019 | 249 | 0.170 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 323 | 0.170 |
Why?
|
| Placenta Accreta | 1 | 2022 | 169 | 0.160 |
Why?
|
| Transducers | 1 | 2019 | 22 | 0.160 |
Why?
|
| Cesarean Section | 1 | 2022 | 418 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 152 | 0.150 |
Why?
|
| Mental Health | 1 | 2022 | 370 | 0.150 |
Why?
|
| Paired Box Transcription Factors | 1 | 2018 | 75 | 0.150 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2019 | 52 | 0.150 |
Why?
|
| Tidal Volume | 1 | 2018 | 41 | 0.140 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 724 | 0.140 |
Why?
|
| Fluoroscopy | 1 | 2018 | 99 | 0.140 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 122 | 0.140 |
Why?
|
| DNA Helicases | 1 | 2018 | 239 | 0.130 |
Why?
|
| Computational Biology | 2 | 2019 | 874 | 0.130 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 232 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2019 | 491 | 0.130 |
Why?
|
| Receptors, Somatomedin | 1 | 2016 | 24 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 699 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2019 | 360 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1178 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1221 | 0.110 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 504 | 0.110 |
Why?
|
| Meningeal Neoplasms | 1 | 2016 | 212 | 0.100 |
Why?
|
| Depression | 1 | 2022 | 1339 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1280 | 0.090 |
Why?
|
| Cerebellar Neoplasms | 1 | 2016 | 459 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2018 | 916 | 0.090 |
Why?
|
| Medulloblastoma | 1 | 2016 | 570 | 0.090 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 3678 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 2493 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 315 | 0.070 |
Why?
|
| Vincristine | 2 | 2019 | 196 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2019 | 111 | 0.070 |
Why?
|
| Animals | 5 | 2019 | 34781 | 0.070 |
Why?
|
| Pregnancy | 3 | 2024 | 7543 | 0.060 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 2022 | 6 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2022 | 3409 | 0.050 |
Why?
|
| Gynecology | 1 | 2024 | 129 | 0.050 |
Why?
|
| Placenta Previa | 1 | 2022 | 67 | 0.050 |
Why?
|
| Female | 7 | 2024 | 70584 | 0.050 |
Why?
|
| Child Health | 1 | 2022 | 68 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 155 | 0.040 |
Why?
|
| Chest Tubes | 1 | 2019 | 37 | 0.040 |
Why?
|
| Suction | 1 | 2019 | 54 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2019 | 120 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 234 | 0.040 |
Why?
|
| PAX3 Transcription Factor | 1 | 2018 | 28 | 0.040 |
Why?
|
| Humans | 8 | 2024 | 131924 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2019 | 104 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 197 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4680 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2018 | 97 | 0.040 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2018 | 72 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 247 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 652 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 382 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 237 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 601 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 127 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1825 | 0.030 |
Why?
|
| Mice | 3 | 2019 | 18460 | 0.030 |
Why?
|
| Equipment Design | 1 | 2019 | 599 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2022 | 843 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1018 | 0.030 |
Why?
|
| Adolescent | 3 | 2022 | 20535 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2016 | 40 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 294 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2016 | 43 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 90 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1127 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2016 | 51 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 990 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 95 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 408 | 0.030 |
Why?
|
| Anxiety | 1 | 2022 | 991 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2016 | 137 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 319 | 0.030 |
Why?
|
| Child | 3 | 2022 | 25761 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 685 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 323 | 0.030 |
Why?
|
| Texas | 1 | 2022 | 3627 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 808 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2311 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3990 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 396 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2024 | 1247 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 754 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 888 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1342 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1558 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1960 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6569 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1881 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 2056 | 0.020 |
Why?
|
| Male | 3 | 2024 | 64870 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8542 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6440 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2507 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11648 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1657 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2019 | 14732 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 31536 | 0.010 |
Why?
|